KR900013950A - (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온 화합물 및 약학적 담체를 함유한 약학적 조성물 - Google Patents
(7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온 화합물 및 약학적 담체를 함유한 약학적 조성물 Download PDFInfo
- Publication number
- KR900013950A KR900013950A KR1019900003574A KR900003574A KR900013950A KR 900013950 A KR900013950 A KR 900013950A KR 1019900003574 A KR1019900003574 A KR 1019900003574A KR 900003574 A KR900003574 A KR 900003574A KR 900013950 A KR900013950 A KR 900013950A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- pharmaceutical composition
- hydroxy
- methyl
- animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Abstract
Description
Claims (9)
- 순수한 결정질이고 기타 다른 결정질 형태를 거의 완전히 함유하지 않는 (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온-구조의 화합물 및 약학적으로 적합한 담체를 함유한 약학적 조성물.
- 제1항에 있어서, 순수한 결정질 화합물은 제1도에 주어지는 바의 스펙트럼에 대응하는 분말 X-선 회절 스펙트럼에 의해 규정되는 화합물인 것을 특징으로 하는 약학적 조성물.
- 제1항에 있어서, 순수한 결정질 화합물은 제2도에 주어지는 바의 스펙트럼에 대응하는 분말 X-선 회절 스펙트럼에 의해 규정되는 화합물인 것을 특징으로 하는 약학적 조성물.
- 제1항 내지 제3항중 어느 한 항에 있어서, 상기 화합물의 결정 순도는 95%이상인 것을 특징으로 하는 약학적 조성물.
- 제2항에 따른 약학적 조성물에 사용되는 순수한 결정질 화합물을 제조하는 방법에 있어서, 다형성 화합물은 극성 용매로 부터 결정되는 방법.
- 제3항에 따른 약학적 조성물에 사용되는 순수한 결정질 화합물을 제조하는 방법에 있어서, 다형성 화합물은 무슥성 용매로 부터 결정되는 방법.
- 제1도 또는 제2도에 주어진 스펙트럼에 대응하는 분말 X-선 회절 스펙트럼에 의해 규정된 (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-온의 치료학적 충분량을 폐경기 증상을 지닌 동물에 투여하는 것을 포함하는 폐경기 증상을 지닌 동물의 치료 방법.
- 제1도 또는 제2도에 주어진 스펙트럼에 대응하는 분말 X-선 회절 스펙트럼에 의해 규정된 (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온의 치료학적 충분량을 면역 결핍 동물에 투여하는 것을 포함하는 면역 결핍 동물의 치료 방법.
- 제1도 또는 제2도에 주어진 스펙트럼에 대응하는 분말 X-선 회절 스펙트럼에 의해 규정된 (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온의 치료학적 충분량을 골다공증 동물에게 투여하는 것을 포함하는 골다공증 동물의 치료 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8900673 | 1989-03-18 | ||
NL8900673 | 1989-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR900013950A true KR900013950A (ko) | 1990-10-22 |
KR0183401B1 KR0183401B1 (ko) | 1999-05-01 |
Family
ID=19854317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019900003574A KR0183401B1 (ko) | 1989-03-18 | 1990-03-17 | (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온 구조의 화합물 및 약학적 허용 담체를 함유한 약학적 조성물 |
Country Status (17)
Country | Link |
---|---|
US (1) | US5037817A (ko) |
EP (1) | EP0389035B1 (ko) |
JP (2) | JP3139709B2 (ko) |
KR (1) | KR0183401B1 (ko) |
AT (1) | ATE98490T1 (ko) |
AU (1) | AU625083B2 (ko) |
CA (1) | CA2011452C (ko) |
DE (1) | DE69005165T2 (ko) |
DK (1) | DK0389035T3 (ko) |
ES (1) | ES2062292T3 (ko) |
FI (1) | FI94865C (ko) |
HK (1) | HK1002019A1 (ko) |
IE (1) | IE63051B1 (ko) |
MX (1) | MX9203787A (ko) |
NZ (1) | NZ232946A (ko) |
PT (1) | PT93488B (ko) |
ZA (1) | ZA901674B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2134313T3 (es) * | 1993-03-05 | 1999-10-01 | Akzo Nobel Nv | Utilizacion de derivados de pregnano para el tratamiento de tumores. |
US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
IL123984A (en) * | 1997-04-22 | 2004-09-27 | Akzo Nobel Nv | Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable |
CN100378116C (zh) | 1998-10-16 | 2008-04-02 | 欧加农股份有限公司 | 包含(7α,17α)-17-羟基-7-甲基-19-去甲-17-孕-5(10)-烯-20-炔-3-酮的高纯度组合物 |
CA2332767A1 (en) * | 1999-03-18 | 2000-09-21 | Genelabs Technologies, Inc. | Dhea composition and method |
US7045513B1 (en) | 1999-03-18 | 2006-05-16 | Genelabs Technologies, Inc. | DHEA composition and method |
TWI265167B (en) | 1999-11-29 | 2006-11-01 | Akzo Nobel Nv | 3-methylene steroid derivatives |
US20040229854A1 (en) * | 2000-11-28 | 2004-11-18 | Pieter Haan De | Immediate release dosage form for HRT |
EP1444247B1 (en) * | 2001-10-18 | 2007-06-13 | Norton Healthcare Limited | Tibolone formulations |
GB0125061D0 (en) * | 2001-10-18 | 2001-12-12 | Norton Healthcare Ltd | Pharmaceutical composition |
JP2005518412A (ja) * | 2002-01-22 | 2005-06-23 | アクゾ・ノベル・エヌ・ベー | 内因性エストロゲンの合成を阻害する薬物の投与に伴う愁訴の治療におけるチボロン |
GB0304927D0 (en) | 2003-03-04 | 2003-04-09 | Resolution Chemicals Ltd | Process for the production of tibolone |
CN1324041C (zh) * | 2003-04-01 | 2007-07-04 | 上海迪赛诺医药科技开发有限公司 | 替勃龙晶型i的制备方法 |
WO2004103378A1 (en) * | 2003-05-23 | 2004-12-02 | Akzo Nobel N.V. | Immediate-release pharmaceutical dosage form comprising polymorphous tibolone |
WO2006125453A1 (en) * | 2005-05-23 | 2006-11-30 | Newchem S.P.A. | Process for the preparation of pure crystalline tibolone |
EP1821571A1 (en) * | 2006-02-15 | 2007-08-22 | Oticon A/S | Loop antenna for in the ear audio device |
ITMI20130120A1 (it) * | 2013-01-25 | 2014-07-26 | Ind Chimica Srl | Processo per la preparazione in forma cristallina di tibolone, (7alfa,17alfa)-17-idrossi-7-metil-19-norpregn-5(10)-en-20-in-3-one |
PL3452019T3 (pl) | 2016-05-04 | 2021-12-20 | Novalon S.A. | Zastosowanie alkoholi cukrowych w kompozycjach tybolonu |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE665514A (ko) * | 1964-06-16 | |||
US4933168A (en) * | 1975-05-27 | 1990-06-12 | Syntex Pharmaceuticals International Limited | Stable, crystalline flunisolide |
US4273710A (en) * | 1979-05-21 | 1981-06-16 | Syntex Corporation | Process for preparing flunisolide |
US4447426A (en) * | 1982-01-18 | 1984-05-08 | E. R. Squibb & Sons, Inc. | Steroid monohydrates, formulations containing same and method |
US4391755A (en) * | 1982-01-18 | 1983-07-05 | E. R. Squibb & Sons, Inc. | Steroid monohydrates, formulations containing same and method |
US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
-
1990
- 1990-02-27 IE IE70990A patent/IE63051B1/en not_active IP Right Cessation
- 1990-03-05 ZA ZA901674A patent/ZA901674B/xx unknown
- 1990-03-05 CA CA002011452A patent/CA2011452C/en not_active Expired - Lifetime
- 1990-03-12 DE DE90200574T patent/DE69005165T2/de not_active Expired - Lifetime
- 1990-03-12 EP EP90200574A patent/EP0389035B1/en not_active Expired - Lifetime
- 1990-03-12 ES ES90200574T patent/ES2062292T3/es not_active Expired - Lifetime
- 1990-03-12 AT AT90200574T patent/ATE98490T1/de not_active IP Right Cessation
- 1990-03-12 DK DK90200574.3T patent/DK0389035T3/da active
- 1990-03-14 JP JP02063921A patent/JP3139709B2/ja not_active Expired - Lifetime
- 1990-03-15 US US07/494,089 patent/US5037817A/en not_active Expired - Lifetime
- 1990-03-16 PT PT93488A patent/PT93488B/pt not_active IP Right Cessation
- 1990-03-16 FI FI901328A patent/FI94865C/fi active IP Right Grant
- 1990-03-16 AU AU51394/90A patent/AU625083B2/en not_active Expired
- 1990-03-16 NZ NZ232946A patent/NZ232946A/xx unknown
- 1990-03-17 KR KR1019900003574A patent/KR0183401B1/ko not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203787A patent/MX9203787A/es unknown
-
1998
- 1998-02-11 HK HK98101031A patent/HK1002019A1/xx not_active IP Right Cessation
-
2000
- 2000-10-17 JP JP2000316716A patent/JP2001139473A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPH0347195A (ja) | 1991-02-28 |
ES2062292T3 (es) | 1994-12-16 |
FI901328A0 (fi) | 1990-03-16 |
DE69005165D1 (de) | 1994-01-27 |
IE63051B1 (en) | 1995-03-22 |
US5037817A (en) | 1991-08-06 |
CA2011452A1 (en) | 1990-09-18 |
KR0183401B1 (ko) | 1999-05-01 |
NZ232946A (en) | 1991-08-27 |
EP0389035A1 (en) | 1990-09-26 |
PT93488A (pt) | 1990-11-07 |
FI94865C (fi) | 1995-11-10 |
HK1002019A1 (en) | 1998-07-24 |
AU5139490A (en) | 1990-09-20 |
EP0389035B1 (en) | 1993-12-15 |
MX9203787A (es) | 1992-07-01 |
CA2011452C (en) | 1999-05-25 |
DE69005165T2 (de) | 1994-05-05 |
DK0389035T3 (da) | 1994-02-14 |
JP3139709B2 (ja) | 2001-03-05 |
AU625083B2 (en) | 1992-07-02 |
FI94865B (fi) | 1995-07-31 |
JP2001139473A (ja) | 2001-05-22 |
IE900709L (en) | 1990-09-18 |
PT93488B (pt) | 1996-02-29 |
ATE98490T1 (de) | 1994-01-15 |
ZA901674B (en) | 1990-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR900013950A (ko) | (7α,17α)-17-히드록시-7-메틸-19-노르-17-프레근-5(10)-엔-20-인-3-온 화합물 및 약학적 담체를 함유한 약학적 조성물 | |
DE2714263A1 (de) | Pharmazeutische zubereitungen, enthaltend triazolopyrimidine | |
IL72702A0 (en) | Steroidal carboxylic acid esters,their manufacture and pharmaceutical compositions containing them | |
PT74078A (en) | Process for preparing 4-pregnene-derivatives and pharmaceutical compositions containing the same | |
AU5791190A (en) | New peptide derivatives, process for preparing them and pharmaceutical compositions containing them | |
ATE8891T1 (de) | Neue 2-aryl-3,4-diaza-bicyclo(4.n.0)alken-(2)-one-(5 , verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
ES8700232A1 (es) | Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol | |
NZ216048A (en) | Quinolylglycinamide derivatives, and pharmaceutical compositions containing such | |
IT1165252B (it) | Procedimento di purificazione dell'acido ursodesossicolico attraverso nuovi derivati | |
IE800341L (en) | Imidazoles | |
KR880009010A (ko) | 신규한 테트라히드로 푸란의 5-옥시 유도체의 제조방법 | |
PH24207A (en) | 2-acylamino-6-amino-4,5,6,7-tetrahydrobenzothiazoles | |
EP0380825A3 (en) | Crystalline aluminophosphates and related compounds | |
RU94046378A (ru) | 17-алкилкетонстероиды, полезные в качестве ингибиторов 5- альфа -редуктазы, промежуточные соединения, способы их получения, фармацевтическая композиция, способ получения фармацевтической композиции, способ ингибирования стероид-5- альфа -редуктазы у млекопитающих | |
HUT43618A (en) | Process for producing 1-methyl-15 alpha-alkyl-androsta-1,4-dien-3,17-dion derivatives and pharmaceutical compositions containing them | |
SE7709317L (sv) | Sett att framstella 2,9-dioxatricyklo(4,3,1,03,7)-dekaner | |
DE3374401D1 (en) | 4-hydroxy-alpha-ethyl benzhydroles, process for their preparation and medicines containing these compounds | |
JPS5373507A (en) | Crystallization of pentaerythritol | |
KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
ES8401095A1 (es) | Procedimiento para la preparacion de 11 -cloro-15-esteroides. | |
JPS5576857A (en) | 24, 24-difluoro-25-hydroxyvitamin d3, its oh-protected derivative, and their preparation | |
JPS5212987A (en) | Manufacture of na glutamate | |
ES465551A1 (es) | Procedimiento para la obtencion de halogenopregnadienos. | |
JPS53137945A (en) | Purification of chenodeoxycholic acid | |
ES8301467A1 (es) | Procedimiento de obtencion de derivados del (2-oxo-pirroli- dina-1)-y del (2-oxo-piperidina-1)-acido carboxilico (acido organico) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
J206 | Request for trial to confirm the scope of a patent right | ||
J204 | Request for invalidation trial [patent] | ||
J301 | Trial decision |
Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20050607 Effective date: 20070323 Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20050509 Effective date: 20070323 |
|
J2X1 | Appeal (before the patent court) |
Free format text: INVALIDATION |
|
J2X2 | Appeal (before the supreme court) |
Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION |
|
J302 | Written judgement (patent court) |
Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20070427 Effective date: 20080320 |
|
J303 | Written judgement (supreme court) |
Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20080416 Effective date: 20100527 |
|
LAPS | Lapse due to unpaid annual fee |